Letter by Liu et al Regarding Article, “Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)”

Guoqing Liu; Chuwen Fu; Jian Xie

doi:10.1161/circulationaha.125.074708

Letter by Liu et al Regarding Article, “Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)”

G Guoqing Liu (School of Physics and Astronomy, Shanghai Jiao Tong University) C Chuwen Fu (Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China (Z.Q., C.F., J.X.).) J Jian Xie (Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center)

View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Circulation

Volume / Issue Vol. 152, Issue 10

Published September 09, 2025

DOI 10.1161/circulationaha.125.074708

ISSN 0009-7322

Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (3)

G

Guoqing Liu

School of Physics and Astronomy, Shanghai Jiao Tong University

C

Chuwen Fu

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China (Z.Q., C.F., J.X.).

J

Jian Xie

Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center

Letter by Liu et al Regarding Article, “Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)”

Article Details

Journal Info

Authors (3)

Related Articles from this Journal

Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations

Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”

Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>

ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction

Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”